We present a droplet-based microfluidics protocol for high-throughput analysis and sorting of single cells. compartmentalization of single cells in droplets enables the analysis of proteins released from or secreted by cells, thereby overcoming one of the major limitations of traditional flow cytometry and fluorescence-activated cell sorting. as an example of this approach, we detail a binding assay for detecting antibodies secreted from single mouse hybridoma cells. secreted antibodies are detected after only 15 min by co-compartmentalizing single mouse hybridoma cells, a fluorescent probe and single beads coated with anti-mouse IgG antibodies in 50-pl droplets. the beads capture the secreted antibodies and, when the captured antibodies bind to the probe, the fluorescence becomes localized on the beads, generating a clearly distinguishable fluorescence signal that enables droplet sorting at ~200 Hz as well as cell enrichment. the microfluidic system described is easily adapted for screening other intracellular, cell-surface or secreted proteins and for quantifying catalytic or regulatory activities. In order to screen ~1 million cells, the microfluidic operations require 2-6 h; the entire process, including preparation of microfluidic devices and mammalian cells, requires 5-7 d.
IntroDuctIon
High-throughput cell-based screens can benefit considerably from the unique liquid-handling capabilities offered by microfluidic systems. This protocol describes the use of two-phase, droplet-based microfluidics systems [1] [2] [3] for high-throughput single-cell analysis and sorting. The basic principle of droplet microfluidic systems is simple: highly monodisperse aqueous droplets flow in an inert carrier oil in microfluidic channels on a chip and each droplet functions as an independent microreactor. Hence, each droplet is the functional equivalent of a well on a microtiter plate. However, the volume of the droplets typically ranges from a few picoliters to a few nanoliters, making the reaction volume roughly a thousand to a million times smaller than in a microtiter plate well (in which the minimum reaction volume is ~1 µl) 4 .
Droplets can be generated and manipulated in a variety of ways. For example, droplets can be split 5 and new reagents can be added to preformed droplets at defined times in a variety of ways, including by passive droplet fusion 6, 7 , electrocoalescence [8] [9] [10] , picoinjection 11 and other techniques 12, 13 . Droplets can be incubated for up to ~1 h in delay lines 14 , or incubated for longer times in on-chip 15, 16 or off-chip reservoirs 17 . Assays in droplets are typically measured using fluorescence detection techniques 18, 19 and droplets can be selectively sorted using systems based on dielectrophoresis 20 or acoustic waves 21 . The sorted droplets are then intentionally broken in order to recover the contents 22, 23 .
Droplet-based microfluidic systems are becoming established as valuable tools for various applications, such as single-cell analysis [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , complex multistep biological and chemical assays 17, [35] [36] [37] , diagnostics [38] [39] [40] , DNA sequencing 41 , drug screening 27, [42] [43] [44] and directed evolution experiments [45] [46] [47] . Droplets can be generated and manipulated at kHz frequencies 3 , and compartmentalization of single cells into pico-or nanoliter droplets enables the highthroughput analysis and sorting of millions of individual cells 1 . Encapsulated cells remain viable for extended periods of time in droplets 25 because of the use of fluorinated carrier oils, which can dissolve ~20 times more oxygen than water 48 . These oils, being both hydrophobic and lipophobic, are very poor solvents for organic molecules 49, 50 and are thus especially well suited for cell-based assays and biochemical assays.
The small volume of the reaction compartments in droplet-based microfluidic systems provides a number of advantages compared with conventional high-throughput screening systems that use microtiter plates and robotic liquid-handling systems. The benefits of assay miniaturization are clearly demonstrated by a directed evolution experiment to improve the activity of horseradish peroxidase on the surface of individual yeast cells 45 . In total, ~10 8 individual enzyme reactions were screened in only 10 h, using < 150 µl of reagents-a 1,000-fold increase in speed accompanied by a marked reduction in reagent cost compared with robotic microtiter plate-based screening.
A particular advantage of droplet microfluidics when compared with conventional screening techniques is that droplets provide a unique tool to link genotype with phenotype through compartmentalization 51 . Cells and molecules secreted by the cells remain trapped inside the droplets throughout analytical and sorting steps 45, 46, 52 . Secreted molecules from single compartmentalized cells quickly reach detectable concentrations because of the small droplet volume 26, 27 , which enables the rapid detection of droplets that contain cells producing molecules of interest. In addition, encapsulated cells can be lysed and intracellular biomolecules assayed 19, 53 . This feature enables biochemical and genetic analyses of cells, as the released DNA or RNA can be amplified in the droplets [15] [16] [17] [54] [55] [56] . Thus, analysis is highly flexible and not limited to the detection of cell-surface markers, which is typically the case when using classical approaches such as FACS 57 . Although the current throughput of droplet-based microfluidic sorting systems (≤2 kHz) is at least an order of magnitude slower than state-ofthe-art FACS 58 , the increased flexibility offered by droplet-based microfluidics systems still offers many advantages.
Individual cells can also be compartmentalized in single-phase microfluidic systems. One powerful system pioneered by the Quake research group, and now commercialized by Fluidigm, features sophisticated microfluidic chips composed of multiple valves 59 . The valves can be closed to form compartments of nanoliter volume, which can sequester single cells. These chips have greatly facilitated high-throughput genetic analysis of single cells [60] [61] [62] ; however, the maximum number of compartments (and hence single cells) that can be analyzed is currently ~4 × 10 4 , which limits throughput. Microfluidic devices, containing arrays of microwells of nanoliter volume, have been used to study the proliferation of single hematopoietic stem cells 62 and to efficiently select single cells that produce antigen-specific antibodies 63 . These microwell systems, although compatible with a wide variety of assays, require cells of interest to be recovered from the wells using a micropipette, making their use difficult in high-throughput cell-selection applications. In contrast, droplet-based microfluidic systems enable the handling of millions of droplets (and cells) in a single experiment, including sorting at high speed 45 and recovery of viable cells from the droplets 22 .
Not all assays are, however, well suited to the droplet format. For example, some biological assays require washing steps, in which reagents from a first reaction must be completely removed before a new set of reagents is introduced. Such heterogeneous assays are difficult to perform inside droplets. Droplet contents can be adjusted through droplet fusion 7 or by injecting a liquid stream 11 ; however, these procedures do not completely exchange a buffer. The range of readouts for assays in droplet-based microfluidic systems is also currently more restricted than that for conventional microtiter plate assays; most droplet-based microfluidic assays are based on fluorescence 64 , including fluorescence polarization 65, 66 and fluorescence resonance energy transfer (FRET) 67 , although other techniques, such as Raman spectroscopy 68 , have been described, and considerable progress is being made toward the goal of developing highly flexible readouts based on mass spectroscopy 35 .
Here we present a detailed protocol for using droplet-based microfluidics for high-throughput isolation of individual, antibodysecreting cells from a large excess of nonsecreting cells. The described principles and methods can be adapted for many applications. For example, by screening for antigen binding, the protocol can be extended to facilitate rapid selection of cells secreting targetspecific antibody. The assay speed (a single cell in a 50-pl droplet secretes enough antibody to allow detection in only 15 min) and the high viability of cells in droplets could enable screening of primary cells isolated from human blood, without the need to immortalize the cells. The fluorescence-based binding assay described can also be easily adapted for measuring any secreted molecule for which a fluorescently labeled ligand exists (insulin, cytokines and growth factors among others). In addition, by using fluorogenic substrates or other fluorogenic assays 69 , the protocol is easily adapted for highthroughput screening and directed evolution of enzymes [45] [46] [47] , or for the screening of antibodies and other molecules that inhibit enzyme activity 22 . This approach can also be used in order to analyze a wide range of cells, including bacteria 32, 52 , yeast 45 , insect 33 and mammalian cells, on the basis of the activities of secreted 26 , cell-surface 23, 70 or intracellular proteins 25, 27 .
Experimental design
In this protocol, we describe the production and use of microfluidic chips for high-throughput single-cell analysis and screening.
We detail three major steps: (i) microfluidic device (chip) design and fabrication, (ii) cell preparation and encapsulation and (iii) single-cell sorting based on fluorescence. In addition, we detail a useful control protocol to evaluate cell growth in conditions that mimic compartmentalization in droplets, and we describe the use of nonsecreting cells to evaluate the efficiency of the sorting process.
Microfluidic device design and fabrication
We use soft lithography 71 to fabricate microfluidic devices in poly(dimethyl siloxane) (PDMS). The process includes: (i) mask design using computer-aided design (CAD) software, (ii) mask printing, (iii) fabrication of the master, (iv) polymerization of the PDMS using the master as a mold, (v) bonding of the PDMS slabs to a glass substrate and (vi) surface treatment of the microfluidic channels (Fig. 1) .
The CAD designs provided as Supplementary Data are optimized for cell encapsulation, analysis and sorting, and they should, therefore, enable the production of microfluidic devices without further modifications (Fig. 2) . However, it is worth emphasizing some key aspects that will enable users to create their own designs and avoid potential errors. We recommend using a flow-focusing junction 72 for generating droplets; this geometry produces stable monodisperse droplets at moderate-to-high capillary numbers and lower oil-to-water flow rate ratios than are possible with T-junctions or other geometries [73] [74] [75] . These devices produce highly monodisperse droplets over extended periods of time. In order to prevent clogging of the junction, passive filters should be incorporated upstream of the nozzle with the smallest dimensions equal to or smaller than the nozzle width. Although wider filters can be used, clogging of the microfluidic device becomes more likely with them than with narrower filters.
In order to stabilize droplets against uncontrolled coalescence, the use of surfactants is necessary 76 . These molecules populate the water-oil interface and prevent droplet coalescence. However, diffusion time and interface stabilization are strongly affected by the properties of the surfactants, and it takes several milliseconds for droplets to become stable against coalescence 7, 77 . Therefore, the channel downstream from the nozzle should keep droplets separated from each other for a sufficient period of time to allow droplet stabilization. For the flow rates specified in the protocol, a channel > 500 µm long, corresponding to a droplet residence time of 5-10 ms, is usually sufficient for droplets to stabilize before they reach the expansion, where they start to collide. Lower surfactant concentrations are possible with longer channels 77 .
The surfactant can interact with encapsulated cells or biological molecules. Therefore, in biological assays, biocompatible surfactants must be used 78, 79 , which do not interfere with biochemical reactions or cellular functions. On the basis of our experience and the available literature data 26, 27, 70, 79 , nonionic surfactants are the best option, in particular those with PEG head groups. When fluorinated carrier oils are used, fluorosurfactants (surfactants with fluorinated tails) are required. Although the range of commercially available fluorosurfactants is much smaller than that of conventional surfactants, biocompatible fluorosurfactants (although expensive) are available from RainDance Technologies, Dolomite and Bio-Rad. Furthermore, instructions in published synthesis protocols 16, 79, 80 enable users to produce their own surfactants. We typically use a triblock copolymer containing two perfluoropolyether (PFPE) tails (M W ~6,000 gmol − 1 ) and a PEG (M W ~600 gmol − 1 ) head group. The PFPE block is considerably larger than the hydrophilic PEG block, making the surfactant highly soluble in fluorinated oil and nearly insoluble in the aqueous phase. Detailed physicochemical characteristics of such a surfactant have been reported recently 7 .
The use of fluorinated carrier oils drastically reduces the solubility of nonfluorinated compounds 49, 81 in the continuous phase. However, some hydrophobic fluorescent dyes, such as coumarin and resorufin, can solubilize in surfactant micelles 82 and partition into the continuous phase, resulting in their exchange between the droplets. In order to minimize leakage and exchange of droplet components, we recommend using hydrophilic assay reagents and dyes. For example, fluorescein, rhodamine 110 and coumarin substituted with the hydrophilic methyl sulfonate moiety 83 do not leak from droplets over a period of several days, and thus fluorogenic substrates based on these dyes are excellent choices for cellbased assays 82, 84 .
The microfluidic device channel surfaces should be made fluorophilic to ensure reliable and monodisperse droplet production. We detail two simple methods for efficient surface treatment. The first is based on the commercial water repellent Aquapel and the second on perfluorododecyltrichlorosilane. At the device outlet, droplets can be collected into Eppendorf-type tubes, glass capillaries or syringes, depending on the volume of emulsion. Once collected, the emulsion can be stored at different temperatures ranging from 0 °C to 42 °C, or higher, if necessary. In order to prevent water loss from the droplet emulsion, it should be stored in a closed system (e.g., syringe or capillary) or in a water-saturated atmosphere.
When experiments require the use of electric fields for applications such as droplet electrocoalescence 8, 27, 37 , picoinjection 11 or droplet sorting 23, 45, 52 , microelectrodes should be prepared by injecting molten solder into preformed channels on the chip, followed by cooling to form solid metallic wires (see 85 .
Cell preparation and encapsulation
Cell preparation is another important aspect of the procedure. The key is the prevention of cell lysis and clumping. Adherent cells should be detached from cell culture flasks by gentle methods. For example, PBS supplemented with 2 mM EDTA, rather than standard trypsin-EDTA solutions, may reach that goal and will reduce cell damage. Traces of DNA from lysed cells, which can aggregate and trap cells and cell debris, resulting in device clogging, can be The device consists of one inlet for the continuous phase (1) and two inlets for different aqueous phases (2) . Fluid resistors (3) are placed for both continuous and aqueous phases to dampen fluctuations arising from the mechanical instability of syringe pumps and the elasticity of the PDMS device. Because of laminar flow inside microfluidic channels, the two aqueous streams injected into the device flow side by side and are completely mixed only after they are encapsulated into droplets at the flowfocusing junction (4) . Droplets leaving the outlet (5) are collected into a tube or syringe. (b) The droplet-sorting device consists of one inlet for the continuous phase (1), one inlet for the re-injected emulsion (6); and two outlets, one for sorted droplets (7) and the other for unsorted droplets (8) .
After spacing the emulsion droplets with carrier oil, they move down to the sorting junction (9) , where individual droplets are sorted on the basis of fluorescence intensity. The edges of microfluidic channels are black, the edges of electrodes are blue, and the red triangle is a mark below the microfluidic channel to indicate where the laser beam should be focused and droplet fluorescence measured. See also supplementary Videos 1-3 and supplementary Data.
effectively removed by DNase I. However, DNase use prevents the amplification of cellular DNA in later steps. Therefore, handling and washing of cells with physiological buffers or growth media in a careful and gentle manner is the most common way to prepare clean cell suspensions. Some applications may require cell prestaining before encapsulation. Various cellular dyes are available commercially for that task. We found that Molecular Probes CellTracker fluorescent probes work efficiently, as they show low background noise and do not leak from cells over a period of a few hours, although this behavior may be cell type-dependent. Cell encapsulation is performed so that the majority of droplets contain no more than one cell (Box 1, Fig. 3 and Supplementary Video 1). Although this protocol results in the formation of some empty droplets, throughput remains high compared with the rate of conventional microtiter plate-based techniques, in which analysis is performed at ~1 cell per s (1 Hz) (ref. 4) . Alternative encapsulation techniques based on Dean-coupled inertial ordering 86, 87 can be exploited in order to increase the fraction of droplets containing single cells to ~80% (ref. 88) , thus increasing the throughput. However, these techniques have been used only for homogenous cell mixtures (or particles) and therefore require further development.
Typically, cell encapsulation requires up to 1 h, and, because cells and growth medium have different densities (1.1 g ml − 1 (ref. 87) and 1.0 g ml − 1 , respectively), cell sedimentation can occur and decrease encapsulation efficiency. To prevent sedimentation, a density-matching solution, such as OptiPrep (iodixanol) 89 , can be added to the growth medium in order to increase its density so that it matches that of the cells. Proper density matching prevents sedimentation and clumping, enabling encapsulation efficiency of beads and cells to remain nearly constant over periods of up to 2 h, without adverse cytotoxic effects 90, 91 . An alternative method for preventing cell sedimentation and aggregation is to place a mini stir bar in the cell suspension syringe 27, 92 . However, cells might be damaged during the mixing process and cells flowing from the syringe into the microfluidic chip must travel through the tubing, where sedimentation can also occur. For these reasons, we prefer to use density-matching solutions to prevent cell sedimentation in the tubing and other parts of the system. After the encapsulation process, droplets containing cells can be stored at 37 °C in a 5% CO 2 atmosphere in a humidified incubator, before further analysis or sorting.
Droplet sorting based on fluorescence
Fluorescence-activated droplet sorting requires specially designed microfluidic devices, which enable the efficient recovery of the desired droplets for further processing. The microfluidic device comprises a re-injection inlet that introduces droplets and an oil inlet that spaces them. The channels from these inlets intersect at the spacing junction (Supplementary Video 2) , which is followed by a Y-shaped junction where droplets are actively sorted (Supplementary Video 3) via dielectrophoresis. Separation is based on the electric force that results from the interaction between a nonuniform, applied electric field and the dipole it induces in the droplet. Once a droplet passes a point at which it is irradiated by a laser and the resulting fluorescence is recorded, the sorting electric field is turned on only if the droplet has a fluorescence intensity above a preselected threshold. This field results in a dielectrophoretic force that attracts droplets toward the region of high
Box 1 | Predicting the number of cells and beads inside the droplets
The number of cells and beads inside each droplet can be estimated using the Poisson distribution 93 , in which the probability P(X = x) of finding x cells (or beads) per droplet is given by the equation
, with λ representing the mean number of cells (or beads) in the volume of each droplet. As a result, droplet occupancy can be tuned by changing the cell density in the aqueous phase. For instance, to encapsulate λ = 0.3 cells in 50-pl droplets, cells should be prepared at a density of 6 × 10 6 cells per ml. Considering that the cell encapsulation process is completely random, this choice of cell density will result in 74.08% of the droplets containing no cells, 22.22% containing a single cell, 3.3% containing two cells and 0.38% containing more than two cells. Following the same approach, we can estimate the number of beads per droplet. If we aim to have a higher average number of beads per droplet, for example, an average of one bead per 50-pl droplet (λ = 1.0), we need to prepare a mixture containing ~5 × 10 7 beads per ml. Assuming that the rates of encapsulation of cells and beads are mutually independent, the probability of co-encapsulation of x 1 cells and x 2 beads in a single droplet is equal to
where λ 1 is the mean number of cells per droplet and λ 2 the mean number of beads per droplet. If the mean number of cells per droplet is λ 1 = 0.3 and the mean number of beads per droplet is λ 2 = 1.0, then the coencapsulation efficiency is field gradient in a manner that depends on the field frequency and the polarizabilities of the droplets and the medium. As the dielectric permittivity of aqueous droplets (ε ~80) is much higher than that of fluorinated oil (ε ~2), a positive dielectrophoretic force pulls the droplet toward the high electric gradient region of the device and diverts it into a collection channel. By switching the electrodes on and off, individual droplets can be sorted at frequencies of up to a few kHz (refs. 20,23,45,52) . The sorting junction is designed so that the collection channel has 1.2-1.5 times higher fluidic resistance than the waste channel. This difference ensures that, with no applied electric field, all droplets flow into the waste channel. The sharp edges of the electrodes generate the largest field gradients and forces on the droplets 20 . However, an excessive localized field gradient around the electrode can deform and break droplets passing through the sorting junction. To avoid these high field gradients, the channel immediately upstream of the sorting junction should be wider than the diameter of a droplet and the applied alternating current (AC) voltage across the electrodes should be minimized to the lowest value that results in droplet sorting (typically ~1.0 kV peak-to-peak amplitude). The spacing between the droplets is also an important factor affecting sorting efficiency 52 . Two successive droplets moving close to each other can collide at the sorting junction forcing one of the droplets to flow into the collection channel. When correctly spaced with carrier oil such that the distance between two droplets is more than 10 times the size of a droplet, the error rate becomes negligible. During re-injection, a small fraction of droplets can experience uncontrolled coalescence; however, such droplets can be distinguished by their size, and by gating on droplet size (in addition to fluorescence) such droplets are not sorted. Developing droplet-based microfluidic systems for selecting antibody-secreting cells is a very desirable research goal. Dropletbased fluorogenic assays have been very effective in screens for enzymatic activity, but they have been difficult to adapt to the screening of binding activity. Assays such as ELISA, which are routinely used to screen for antibody binding in microtiter plates, require washing steps and are difficult to implement in droplet-based microfluidic systems. Here we describe a novel assay to screen for cells secreting antibody in 50-pl droplets. We illustrate the implementation of the protocol on a mixture of 9E10 cells (mouse hybridoma cells that secrete IgG antibodies against human c-MYC protein) and K562 cells (human chronic myelogenous leukemia cells that do not produce antibodies), with the latter serving as a negative control. The binding assay requires no washing step and is based on the concentration of fluorescence signal on a bead coencapsulated with each cell. In this sandwich assay, the secreted antibodies are captured on the bead surface and detected using a fluorescently labeled secondary antibody. As a result of this interaction, the fluorophore in the droplet becomes concentrated on the bead, thereby generating a clearly distinguishable signal (Figs. 4 and 5) . Finally, droplets containing fluorescent beads and coencapsulated cells are selected using a microfluidic sorter. We chose a relatively large droplet size (50 pl) to improve cell viability and coencapsulation rate. Because of the large droplet size, the throughput of the sorting step in this protocol is 5-10 times lower than that in previous reports 45, 46, 52 . This decrease in throughput derives mainly from the fact that larger droplets are more likely to break apart if they impact the sorting junction at high speeds, meaning that more consistent results are obtained by operating at lower sorting rates. However, as the throughput of microfluidic sorting is inversely proportional to the size of the droplets, for applications that do not require large droplets, the sorting rate can be increased above 1 kHz. Overall, the microfluidic system described in this protocol should be easily adapted to screen single cells for other binding interactions, as well as for catalytic or regulatory activities.
The ELISA-type sandwich assay detailed in the Supplementary Note is a useful control experiment for testing cell viability and secretory activity of antibody-secreting cells in conditions that mimic compartmentalization in droplets (i.e., at high concentration and in the presence of OptiPrep). We also used this control assay to confirm that antibody is secreted from cells and is not simply leaking from the cells owing to incubation in the presence of OptiPrep. In these experiments, we cultured cells in growth Two types of cells (orange and gray ellipses) are introduced together as a cell suspension into a microfluidic device together with a bead suspension. One cell type produces mouse antibodies (gray) and the other does not (orange), with the latter being in 10-fold excess. The bead suspension contains green fluorescent-labeled goat detection antibodies (green) and streptavidin beads coated with goat anti-mouse-Fc capture antibodies (magenta). Because of laminar flow, the two suspensions are only mixed inside the droplets, which are created by flow focusing with fluorinated oil containing fluorosurfactant and then collected off-chip at 4 °C. After incubation for 15 min at 37 °C and 5% CO 2 , those beads that are coencapsulated with an antibody-producing cell become highly fluorescent, due to the capture of secreted antibodies on the bead by the anti-mouse Fc antibody and binding of the green fluorescence detection antibodies to the captured antibodies in a sandwich assay. The emulsion is then introduced into a second microfluidic device and droplets containing green fluorescent beads are sorted using a fluorescenceactivated droplet sorter. Hence, droplets containing no bead, no cell, a cell which does not secrete antibody, or an antibody-producing cell but no bead are discarded (no green fluorescent bead is present), whereas droplets containing an antibody-producing cell and a bead (which becomes fluorescent) are collected. The three micrographs show coencapsulation of cells with beads (left), droplet re-injection after incubation off-chip (middle) and droplet sorting (right). Ab, antibody. These imaging experiments also enable the user to measure the actual enrichment, independent of that reported by the sorting instrument. In addition, the fact that CMRA does not leak from the K562 cells indicates that the cells remain viable over the course of the entire encapsulation and sorting process. Figure 6 . The expanded laser beam (Melles-Griot 85-BCD 050-115) passes a cylindrical lens of 200-mm focal length (Thorlabs LJ1653RM-A) arranged to focus at the receiving image plane of the microscope objective. We use a Nikon Diaphot cube for a 488-nm laser (Chroma z488rdc-C126912) to route that light to the sample through the microscope objectives. The beam image formed through a ×20 objective is a long narrow slit of 488-nm illumination having full width at half maximum of ~7 µm perpendicular to the direction of fluid flow in the microchannel when
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correctly aligned. Both epi-and trans-images from the sample pass through a 500-nm long-pass filter (Chroma HQ500LP) mounted on the cube to pass light to the microscope's side port or the eyepiece. This long pass filter prevents 488-nm photons from entering the eyepieces and photomultiplier tubes (PMTs). A pinhole aperture is placed in the image plane of the microscope side port and is aligned by direct observation to the location of the laser image on the sample. This aperture should be adjusted as detailed in the alignment procedure (Box 2) to reject background fluorescence emanating from outside the droplet. Note that in this protocol, the third PMT is not obligatory; however, some biological applications might require a third optical dye. For example, a third fluorescent dye could be used to indicate cell viability or for optical bar-coding of drug compounds 27, 42 . Custom LabVIEW data acquisition and control software We use custom LabVIEW 2009 software on a PC with a National Instruments FPGA data acquisition card (PCIe-7842R) to record droplet fluorescence intensities and trigger the electrodes during sorting. The emitted fluorescence is detected with PMTs ( Fig. 6 ) converted into corresponding signal output voltages, filtered if necessary and recorded by the data acquisition card. These voltages are then processed by the FPGA card to identify droplets according to their fluorescence intensity and size (which is calculated from the residence time in the laser spot and can be used to rule out droplets that have undergone coalescence). These characteristics are used in determining whether each droplet should be sorted. When the PMT voltage exceeds a defined threshold and the droplet size is in the expected range (±5% of the expected size), the electrodes are activated after a defined delay time that corresponds to the time it takes for a droplet to travel from the detection point to the sorting site in the channel. The frequency and length of electrode activation can also be varied accordingly. The computer's CPU runs the user interface, allowing the operator to preview the data and interact with the instrument. Various parameters, including the thresholds for droplet detection and sorting, the gain of the PMTs and the cutoff frequency of the software noise filters can be tuned for best results. Data are streamed from the FPGA to the CPU, which displays them for the user and writes them to the hard disk, providing a record of each run. The data acquisition rate for the system is 100 kHz. The software can be accessed upon request by academic users through Harvard's SEAS Code Respository (1). Figure 6 | Schematic of the optical setup. The fluorescence of each droplet is measured as the droplet flows past an observation constraint (OC) in the microfluidic channel in which the whole droplet is constrained to have a cross-section area of 20 × 25 µm as it passes an optical measurement fiduciary mark on the chip. In this OC, a 50-pl droplet will extend to be ~100 µm in length. The fluorescence measurement setup uses a 50-mW, 488-nm laser and a Nikon Diaphot epi-illumination microscope. Between the laser and the epi-illumination port of the microscope are 'shaping optics' whose task is to form the beam to a narrow line and present it at the input epi-image plane of the Diaphot's 160-mm tube objectives. A Thorlabs OSL1 visible light illuminator is mounted through a 600-nm long-pass filter to provide optional transillumination to the sample and allow simultaneous trans and epi work if needed. The microscope has a side port, where we place the optics for three PMTs to detect three different colors. The microscope contains an internal prism that we use to send 80% of the light collected by its objectives to the PMTs, whereas 20% is routed to the microscope eyepieces. This 80/20 split enables us to mount a digital high-speed camera in one eyepiece to do simultaneous transmission imaging video and three-color-PMT-based fluorescence measurements.
manufacturer's processing guidelines available online (http://www.microchem.com/Prod-SU8_KMPR.htm). In the rest of the PROCEDURE, we provide instructions for obtaining 25-µm-deep microfluidic channels using SU-8 2025.
4| (Optional) Usually, Si wafers arrive clean; however, if there are traces of organic material on the surface, clean the wafers as follows: immerse the wafer in a crystallizing dish filled with acetone and sonicate it for 2-5 min; transfer the wafer into a glass crystallizing dish filled with methanol and sonicate again for 1-2 min; remove the wafer and rinse it thoroughly with isopropanol; blow the isopropanol off with pressurized nitrogen and heat the wafer in a 200 °C oven for 2-5 min to vaporize any leftover solvent.
5|
Line the bowl of the spin coater with aluminum foil; place the wafer into the spin coater and dispense ~3 ml of SU-8 2025 onto the center of the wafer.  crItIcal step Avoid trapping air bubbles in the dispensed SU-8 photoresist, as it can distort the quality of SU-8 structures in the later steps.
6|
Engage the vacuum and ramp up the rotational speed (at a rate of 300 r.p.m. s − 1 ) to 500 r.p.m. and spin for 15 s; thereafter, ramp up the rotational speed at the rate of 500 r.p.m. s − 1 to 3,000 r.p.m. and hold at that speed for 30 s to create a flat resist layer of the desired thickness.
7|
Prebake the spin-coated wafer by placing it on a 65 °C hot plate for 1 min.  crItIcal step Ensure that the hot plate is leveled so that the coated layer does not flow and cure unevenly.
8|
Bake the wafer at 95 °C for 3 min. Note that overbaking does not reduce the quality of the subsequent steps.  crItIcal step Air bubbles should be removed during the soft baking by gently tapping them with a needle tip.
9| Allow the substrate to cool to room temperature (22-23 °C).
? trouBlesHootInG 10| Place the photomask on top of the substrate and expose the wafer according to the specifications in the MicroChem SU-8 data sheet available online (http://www.microchem.com/Prod-SU8_KMPR.htm) and the power of your UV source. We typically use a value of 20 s (exposure energy ~10 mJ cm − 2 ) for a 25-µm layer device.
11|
Place the substrate on a 65 °C hot plate for 1 min, and then transfer it to a 95 °C hot plate for 3 min.
12|
Place the substrate on a solid surface and let it cool to room temperature for 20-30 s.
? trouBlesHootInG 13| Submerge the wafer in PGMEA with the SU-8-coated side up and agitate for development either by putting the container on an orbital shaker and gently agitating for ~4 min or by placing the container in an ultrasonic bath for ~1 min. The orbital shaker provides thorough development of the patterned wafer; the ultrasonic bath develops the wafer faster, but this may result in delamination of the desired features. ! cautIon PGMEA is highly flammable. Conduct this step rigorously in a fume hood. ? trouBlesHootInG 14| By using wafer-handling tweezers, remove the wafer from the crystallizing dish and let the liquid drain. Rinse the wafer with isopropanol.
15| Dry the wafer gently with nitrogen.  crItIcal step The appearance of a whitish residue on the surface of the substrate indicates underdevelopment. If such a whitish residue is observed, repeat Steps 13-15 until no whitish residue remains.
16| (Optional) To improve the adhesion of SU-8 to the substrate and to anneal any cracks formed on the SU-8 surface, you may place the wafer on a 150 °C hot plate (or oven) for 10-30 min. Then slowly cool the substrate to room temperature.
17|
Use a stereomicroscope to determine the quality of the developed features. To measure the height of the features, use a profilometer or an ellipsometer.  pause poInt At this step, the wafer can be transferred into a plastic Petri dish or stored at room temperature in a dustfree, dry and dark environment before use. It will be stable indefinitely in these conditions. preparation of the pDMs mold • tIMInG 2-12 h 18| Place the completed master wafer in a plastic 100-mm-diameter Petri dish. 20| Pour the PDMS mixture into the Petri dish ~5 mm deep and place the Petri dish in a vacuum desiccator. Release the vacuum periodically to prevent the foam from spilling out of the dish.
19|
21|
Degas the PDMS until no bubbles remain attached to the device features and no new bubbles are being formed. Usually 5-10 min is sufficient. If a few bubbles persist, blow gently on the PDMS surface using an air blower or canned air to break the bubbles.
22|
Bake the PDMS in a 65 °C oven on a flat, level surface for at least 2 h to cure the PDMS. We have noticed that curing overnight gives better quality PDMS slabs.  pause poInt After curing, the whole Petri dish can be transferred to room temperature and kept for an unlimited period of time before proceeding to the next step.
23|
Cut the PDMS slab with a scalpel and gently peel the PDMS from the silicon wafer.  crItIcal step Please note that exerting excessive force will cause the wafer to shatter. ? trouBlesHootInG
24|
Cover the nonpatterned side of the PDMS slab with frosted Scotch tape, and then place the device on a cutting mat with the channels facing upward.
25|
Use a biopsy punch to create holes at each fluid inlet or outlet. Devices with microelelectrodes require additional holes, at a different punch diameter, for efficient solder filling.  crItIcal step The size of the biopsy punch should be 1.2-1.5 times smaller than the outer diameter of the tubing to be used. We use a 0.75-mm-diameter biopsy punch for PE-2 tubing (Intramedic) or PTFE microtubing with outer diameters of ~1 mm. For microelectrode channels, we use a 0.5-mm-diameter biopsy punch. ? trouBlesHootInG 26| Cover the patterned side of the PDMS with frosted Scotch tape so that both sides of the PDMS slab are now covered. Place the device, channel side down, on your work surface. Peel off the Scotch tape from the top side. This will remove most of the debris that results from PDMS hole punching.
27|
Remove the Scotch tape from the patterned side and use sharp tweezers to remove any PDMS plugs that remain lodged inside the ports.
28|
Flush the PDMS slab holes with isopropanol to ensure complete removal of PDMS debris. Dry under a stream of nitrogen.
29| Select a substrate (50 mm × 75 mm) to seal the PDMS microfluidic device. Use regular glass slides for encapsulating cells within droplets, or use other applications that do not use electrodes; use a glass slide coated with ITO for devices that use microelectrodes. The latter choice permits electrical grounding of the device and reduces undesired electrocoalescence of droplets within the device during sorting. Use an ohmmeter to determine which side is coated with ITO.
30|
Place the PDMS slab and the glass slide in the plasma chamber with the channel side facing upward. If ITO glass is used, the ITO coating should be facing downward.
31| Plasma-treat the PDMS slab and the glass slide together. The parameters for plasma treatment depend on the type of machine. For the oxygen plasma cleaner referred in the Materials (GaLa Instrumente, Plasma Prep 2), use the following settings: plasma burst = 10 s, power = 2.5, oxygen level = 8-10.  crItIcal step This step must be performed carefully, as it is essential that the binding of the PDMS slab to the glass is strong; otherwise, delamination will occur during microfluidic operations. ? trouBlesHootInG
32|
Remove the PDMS slab and the glass slide from the chamber and bring the plasma-treated faces into contact. Gently press the PDMS so that all parts are sealed to the glass. ? trouBlesHootInG
33|
Place the device in a 65 °C oven for 5-10 min.  pause poInt The device can be stored in the 65 °C oven for several days. Alternatively, after incubation at 65 °C for 5-10 min, the device can be transferred to room temperature and stored indefinitely in a clean environment before proceeding further.
Microelectrode manufacture • tIMInG 10-30 min 34| Place the device on a 90 °C hot plate for 3-5 min.
35| Cut ~5 cm of low-melting-temperature solder wire and use tweezers to insert it into the electrode channels. Solder bends easily; thus it should be held close to the tip. Upon insertion, the solder should melt immediately and start filling the microchannel. Continue pushing the solder into the hole until molten solder emerges from the outlet. ! cautIon Be careful not to burn yourself while working on the hot plate. A face shield should be worn for protection from molten solder spatters.
36|
Remove any excess solder using the tweezers to gently scrape solder from the PDMS surface.
37|
Insert metal pins into each end of the filled electrode channel. Verify electrical contact using a digital multimeter. ? trouBlesHootInG
38|
Cool the device to room temperature and load it into the oxygen plasma cleaner. Expose the surface to oxygen plasma for 10 s using the following settings: power = 10, oxygen level = 8-10.
39|
Apply Loctite 352 around the electrode pins and expose the device to UV light for 30-60 s. ! cautIon Avoid direct exposure to UV light; it is mutagenic.  crItIcal step Keep the exposed pins clean, as dirt can break or ruin the connection to electronic equipment.
Device surface treatment • tIMInG 5-10 min 40| Prepare the surface-treatment solution required for all droplet operations. We typically use option A, but if droplet generation is hampered as a result of wetting effects, option B should be applied.
(a) preparation of aquapel water-repellent solution (i) The Aquapel solution is supplied in a glass ampule embedded in a thick felt pad. Carefully cut the pad and remove the ampule. (ii) Place the ampule at the bottom of a 15-ml Falcon-type conical plastic tube and score the ampule using a diamond pen or similar. Carefully break the ampule inside the tube. (iii) Transfer the Aquapel solution into a 5-ml glass, gas-tight syringe, while leaving the broken glass in the 15-ml plastic tube.  crItIcal step Remove air bubbles from the syringe. Upon prolonged contact with air, Aquapel precipitates and loses its functionality. Aquapel can be stored for up to ~2 weeks by preventing air contact. 41| Attach a 0.22-µm Millipore filter and a 23-gauge needle to the syringe and affix PTFE microtubing to the needle.
42|
Insert the microtube into the continuous-phase inlet of a single microfluidic module, and then inject the surfacetreatment solution to fill each of the device channels.
43|
Leave the solution in the channels for 10-30 s, and then flush with pressurized air or nitrogen.
44|
Rinse the microfluidic channels with pure FC-40 oil to remove the unreacted silane, and then flush every module with pressurized air or nitrogen.
? trouBlesHootInG  pause poInt Devices can be stored at room temperature for weeks or months before use. To prevent degradation of treated surfaces, avoid direct sunlight. Device surfaces should be covered with Scotch tape to keep dust from the openings. 46| 9E10 cells grow as semiadherent cells and can be passaged by transferring a fraction of the cells growing in suspension (typically 2 ml) to a fresh flask containing 18 ml of prewarmed culture medium.
47|
Remove an aliquot of 9E10 cell culture supernatant and count the cells using a hemocytometer.
48|
Transfer a volume of the cell culture supernatant that contains an excess of the cells required ( > 2 × 10 5 , as some cells will be lost during centrifugation) to a 15-ml conical tube. 
49|
56|
Remove an aliquot of K562 cell culture supernatant and count the cells using a hemocytometer. Transfer a volume of cell culture supernatant that contains an excess of the cells required ( > 2 × 10 6 , as some cells will be lost during centrifugation) to 15-ml conical tube(s).
57|
Pellet the cells by centrifugation at 350g for 5 min and replace all supernatant with 10 ml of DMEM prewarmed at 37 °C, not supplemented with FBS or antibiotic, containing 0.2 µM CMRA dye.
58|
Incubate the cell suspension at 37 °C in 5% CO 2 for 30 min.
59|
Pellet the cells by centrifugation at 350g for 5 min and replace all supernatant with 10 ml of complete DMEM (prewarmed at 37 °C). Transfer ~1.4 × 10 6 cells to a 15-ml conical tube and incubate the cells at 37 °C in 5% CO 2 for 10 min.
60| Place the cells on ice for 10 min.
61|
Pellet the cells and carefully remove all supernatant. Resuspend the pellet in 84 µl of ice-cold complete DMEM and add 16 µl of OptiPrep medium.
62|
Combine the 100-µl 9E10 cell preparation from Steps 45-53 with the 100-µl K562 cell preparation to generate a suspension with a 1:10 ratio of 9E10:K562 cells.
preparation of beads • tIMInG 1.5 h 63| Transfer ~4 × 10 6 streptavidin-coated beads to a fresh 1.5-ml Eppendorf tube (use the manufacturer's data sheet to determine concentration of supplied beads or count them using a hemocytometer).
64|
Centrifuge the beads for 1 min at 2,000g at room temperature, carefully remove the supernatant with a 200-µl pipette, and then resuspend the beads in 100 µl of PBS. Repeat this step twice to complete initial washing. cell encapsulation • tIMInG 1 h 68| Place 300 µl of pure HFE-7500 oil in a sterile 1-ml syringe. Transfer the 200-µl 9E10/K562 cell suspension to the oil surface using a pipette. The density of the cell suspension (~1.1 g m − 3 ) is lower than that of HFE-7500 (1.614 g m − 3 ), and it will remain on top of the oil.
69|
Place a 23-gauge needle on the syringe, connect it to PTFE microtubing and place it on a vertically oriented syringe pump with the needle facing upward.  crItIcal step Use an ice-cold jacket to cool the syringe containing the cells during the encapsulation step. This stratagem minimizes cell secretion during the encapsulation process.
70|
In the same way as in Steps 68 and 69, load a second syringe with the mixture containing antibody-capture beads and the labeling antibody.
71|
Prepare a third syringe for the continuous phase, with HFE-7500 oil containing 1.5% (wt/wt) fluorinated surfactant.
72|
Connect the syringes to the corresponding inlets of the microfluidic chip via PTFE microtubing and start infusing. Use flow rates of 90 µl h − 1 for the cell suspension, 90 µl h − 1 for the bead solution and 180 µl h − 1 for the continuous phase. When using this chip design (provided as supplementary Data) and 25-µm-deep channels, 50-pl droplets should be generated at ~1,000 droplets per second (supplementary Video 1 and supplementary Fig. 1 ).
? trouBlesHootInG
73|
In order to collect the encapsulated cells, connect PTFE microtubing to the device exit and place the tubing outlet inside a vertically oriented 1-ml syringe or in a 1.5-ml Eppendorf-type tube. In either case, prefill the collection vessel with 100 µl of the continuous phase and place the tubing outlet in this fluid. This maneuver prevents droplet breakage due to contact with dry surfaces. A cooling jacket should be used to keep the collection vessel at ~4 °C.
? trouBlesHootInG emulsion storage off-chip • tIMInG 15-30 min 74| After the encapsulated cell/bead emulsion is collected, place the collection vessel in a cell culture incubator for 15 min to facilitate antibody secretion.  crItIcal step The air in the incubator should be water saturated to prevent evaporation from the top layer of droplets.
analysis of droplets • tIMInG 5-10 min 75| Droplets are easily visualized by the use of Vitrocom glass capillary tubes. Prewet a tube by quickly dipping the end into HFE-7500 containing surfactant. Touch the same end into the surface of the droplet emulsion. Droplets will quickly wick into the capillary.
76|
Lay the tube on a microscope slide and seal the tube ends with vacuum grease. Droplets can now be easily observed by microscopy. Alternatively, a hemocytometer or standard glass slide and microscope cover slip can be used to trap and observe drops; however, care must be taken to prevent droplet evaporation and merging. ! cautIon The negative electrode should be grounded for safety.
79|
Attach the ITO surface of a microfluidic chip (facing the microscope stage) to the ground electrode using alligator or similar clips.
80| Attach a 27.5-gauge needle to the emulsion-containing syringe, insert PTFE microtubing and place it on a syringe pump with the needle facing up. Set the infusion rate to 500 µl h − 1 and push the emulsion through the tubing until it reaches the end. Stop the flow and insert the tubing into the injection port of the microfluidic device.
81|
Connect a second 2.5-ml syringe filled with HFE-7500 oil containing 1.5% (wt/wt) fluorinated surfactant to the oil inlet of the device and infuse at 200 µl h − 1 . Set the emulsion flow rate at 50 µl h − 1 , until the droplets enter the device channels and then reduce the flow rate to 20 µl h − 1 . Allow a few minutes for the flow inside the microfluidic chip to stabilize. ? trouBlesHootInG 82| Set the oil and emulsion flow rates at 480 µl h − 1 and 20 µl h − 1 , respectively. At these rates, droplets are sufficiently spaced by the carrier oil and will not collide at the sorting junction (supplementary Video 2).
83|
Move the microscope field of view to the sorting junction (Fig. 2b) . All droplets should flow into the negative arm (waste channel). Increase the continuous-phase flow rate if some droplets flow into the sort channel while the electrodes are off.
84|
Focus the laser spot of the optical setup (Fig. 6 ) on the section of channel above the triangular fiducial mark (Fig. 2b , red triangle in inset 5). Start LabVIEW and load the custom data acquisition and control software. Fluorescence traces corresponding to droplets should become visible on the data acquisition software. Adjust the focus and laser spot position to obtain the highest signal-to-noise ratio for fluorescence peaks. ! cautIon Wear proper safety goggles when operating the laser and ensure that the laser has appropriate safety interlocks.
85| By using LabVIEW software, adjust the detection threshold so that all green fluorescent droplets are detected.
? trouBlesHootInG 86| Tune the sorting parameters. We apply a burst of 60 square pulses with an amplitude of 0.6-0.8 kV, output frequency of 30 kHz and sorting delay of 100 µs.
87|
Reduce the sorting threshold to the same level as the detection threshold. Upon electrode activation, all the droplets should be directed into the positive arm (collection channel), thus confirming effective dielectrophoretic sorting. Repeat
Steps 84 and 86, adjusting the sorting parameters as necessary, until droplets are sorted reproducibly into the collection channel only when the sorting signal is applied. ? trouBlesHootInG 88| Once proper sorting conditions are identified (supplementary Video 3), install collection tubing and collection tubes, set the desired sorting threshold and sort the droplets until the desired number of droplets are collected.
89| (Optional) Use a high-speed camera (e.g., Phantom V7.2) to record digital movies during the sorting and observe the sorting errors. We strongly recommend implementing this optional step because it enables monitoring of the sorting process so that relevant parameters can be adjusted as needed.
90|
After sorting is complete, turn off the electrodes, unplug the collection tubing from the microfluidic device and let the oil from the tubing drain into a collection tube. In this way, droplets that were trapped inside the tubing will be collected without any loss.
analysis of sorted droplets • tIMInG ~1 h 91| Aqueous droplets float on HFE 7500 oil; therefore, sorted droplets accumulate at the air-oil interface in the collection tube. A layer of droplets should be visible after sorting. Use the Vitrocom glass capillary tubes as described in Step 75 to prepare the droplets for imaging using fluorescence microscopy.
92|
Calculate the enrichment of antibody-secreting cells using the following equation 52, 93 : 
93|
Cells trapped inside the droplets should be released before propagation in a cell culture dish or before analysis using conventional techniques 26 . For this purpose, first add 500 µl of fresh cell culture medium on top of the sorted droplets.
94| Add a volume of PFO equal to the volume of the continuous phase.
95|
Gently mix the PFO with the continuous phase by tapping the tube with a finger.
96|
Leave the tube on the bench for 1-2 min. Once droplets are broken, the interface between oil and growth medium becomes clear and the two phases appear completely separate. ? trouBlesHootInG 97| Spin the tube at 60g for 10 s at room temperature to fully separate the two phases. Collect the supernatant containing the cells and transfer it to a cell culture flask or microtiter plate well. Do not spin the tube longer or with higher force, as this may pin the cells to the oil phase and reduce the yield. ? trouBlesHootInG ? trouBlesHootInG Troubleshooting advice can be found in table 1. 
antIcIpateD results
Upon completion of the experiments described in this protocol, one should be able to manufacture droplet-based microfluidic chips and use them for single-cell analysis and sorting in a high-throughput manner. As a specific example, here we describe a binding assay to detect antibody production from single mouse hybridoma cells. We use two cell types, 9E10 cells and K562 cells, at densities in which the latter are present at an approximately tenfold excess. Single cells are co-compartmentalized in 50-pl droplets together with 6-µm-diameter beads coated with antibodies directed against the Fc fragment of mouse IgG antibodies. A labeling probe (antibody directed against the Fab fragment of mouse IgG antibodies and labeled with DyLight 488 fluorescent dye), is also co-compartmentalized in the droplets. Mouse IgG antibodies secreted from single cells in droplets are detected using a sandwich assay, which, in contrast to standard ELISA assays, does not require any washing steps.
Secreted antibodies are captured on the bead surface, and they recruit the labeling probe that is present in the same droplet (Fig. 4) . In the absence of binding activity, the fluorescence signal remains distributed over the entire droplet volume, but, upon binding, the fluorescent probe becomes concentrated onto a bead, leading to a clearly distinguishable fluorescence spike (Fig. 5) . Because of the small reaction volumes, the secreted antibodies can reach detectable levels within 15 min. The rate of antibody secretion per cell over the first 30 min was measured to be ~4 × 10 4 molecules per cell per minute, resulting in high and detectable concentrations (~20 nM) after only 15 min.
Confinement in droplets can, however, also impose some strain on the cells. Depletion of the nutrients inside the droplet may impair cell functions or even cause cell death. To slow cellular metabolism, we keep encapsulated cells at 4 °C during all the microfluidic steps and induce protein secretion by shifting the emulsion to 37 °C for ~15-30 min. Droplets containing fluorescent beads were dielectrophoretically sorted at ~200 Hz frequency, using a microfluidic chip (Fig. 2b) whose design is provided as supplementary Data.
We used a custom LabVIEW script that detects fluorescence intensity and sends short electric pulses to the electrodes to direct droplets into the collection channel as they pass the sorting junction (supplementary Video 3). The sorting threshold was set such that all the droplets having a fluorescence intensity three times higher than the background signal were sorted and collected off-chip into an Eppendorf tube. Approximately 1,000 sorted droplets were then imaged using a fluorescence microscope. We calculate the enrichment, η, as After a single round of sorting, we obtained ~220-fold enrichment of 9E10 hybridoma cells ( Fig. 7 and table 2 ). According to statistical modeling of cell encapsulation 94 and sorting 52 , the enrichment in heterogeneous cell mixtures (composed of two or more cell types) is limited by the coencapsulation probability of positive and negative cells. During the sorting step, droplets having at least one positive cell will be sorted regardless of the number of negative cells coencapsulated into the same droplet. After sorting, out of over 1,000 droplets analyzed, only one contained a single negative cell, whereas 47 droplets contained at least one positive and one negative cell (table 2) . At the expense of reducing throughput, enrichment can be further improved by diluting the initial cell mixture to λ = 0.1 (or less), as at low λ values coencapsulation events become negligible.
The microfluidic system described is easily adapted to the screening of other cell types, including bacteria 32, 52 , yeast 45 , insect 33 or other mammalian cells [25] [26] [27] 70, 80, 95 . The system can also be tailored to screen for other activities. For example, antibodies (or other proteins) can also be screened for inhibitory activities 22 . In this case, the beads are omitted and the enzyme to be inhibited is coencapsulated directly with the cells. After incubation, a fluorogenic substrate can be added by drop fusion, and then fluorescence can be measured after a short incubation. Adapting the system to the detection of the catalytic activity of intracellular, cell-surface or secreted proteins is even easier. For cell-surface or secreted proteins, the cells are co-compartmentalized directly with a fluorogenic substrate 45 . The procedure is easily modified for screening intracellular proteins: if required, cell lysis agents are added to the cells immediately before compartmentalization in droplets 19, 46 . 
